Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 2/2024

28.04.2023 | Original Contributions

Prevalence and risk factors of mild cognitive impairment in a tertiary care setting in Turkey

verfasst von: Betül Gülsüm Yavuz Veizi, MD, Candeniz Avci, MD, Hatice Tuğba Yazir, MD, Mehmet Ilkin Naharci, MD, PhD

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Mild cognitive impairment (MCI) is an intermediate stage between healthy cognition and dementia, particularly Alzheimer’s disease. There is limited information on the prevalence of MCI among older Turkish adults. This study aimed to determine the prevalence and risk factors of MCI in Turkey.

Material and methods

A cross-sectional study was conducted with community-dwelling older people who were admitted to a tertiary geriatric outpatient clinic. Information on demographics and clinical variables was obtained. We used a neuropsychological battery to assess the cognitive domains in each subject. Participants who fell below 1.5 standard deviations on 1 or more of the 5 cognitive tests were considered MCI and were classified as either single domain MCI and multiple domain MCI. Risk factors were determined using univariate and multivariate logistic regression analyses.

Results

A total of 259 participants were enrolled in this study. The mean age was 74.0 years (SD 7.1 years), 54% were women, and 48.3% had a low level of education (≤ 5 years). The overall prevalence of MCI was 52.1%, with 27.8% for single domain MCI and 24.3% for multiple domain MCI. The prevalence of MCI increased with age: 16.4% aged 65–74 years, 32.0% aged 75–84 years, and 40.9% ≥ 85 years. Advanced age and low educational level were risk factors for both single domain MCI (OR = 1.07; 95% CI: 1.02–1.13; p = 0.003 and OR = 3.18; 95% CI:1.7–6.1; p < 0.001) and multiple domain MCI (OR = 1.1; 95% CI:1.1–1.2; p < 0.001 and adjusted OR = 11.9; 95% CI:5.1–27.8; p < 0.001).

Conclusion

MCI was common in older Turkish people admitted to a tertiary hospital, especially in those with advanced age and low educational level.
Literatur
1.
Zurück zum Zitat Prince MJ et al (2015) World Alzheimer report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends Prince MJ et al (2015) World Alzheimer report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends
2.
Zurück zum Zitat Petersen RC (2016) Mild cognitive impairment. Continuum (Minneap Minn) 22(2 Dementia):404–418PubMed Petersen RC (2016) Mild cognitive impairment. Continuum (Minneap Minn) 22(2 Dementia):404–418PubMed
3.
Zurück zum Zitat Dunne RA et al (2021) Mild cognitive impairment: the Manchester consensus. Age Ageing 50(1):72–80CrossRefPubMed Dunne RA et al (2021) Mild cognitive impairment: the Manchester consensus. Age Ageing 50(1):72–80CrossRefPubMed
4.
Zurück zum Zitat Lonie JA et al (2009) Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 24(9):902–915CrossRefPubMed Lonie JA et al (2009) Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 24(9):902–915CrossRefPubMed
5.
Zurück zum Zitat Ganguli M et al (2005) Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol 62(5):779–784CrossRefPubMed Ganguli M et al (2005) Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol 62(5):779–784CrossRefPubMed
6.
Zurück zum Zitat Jia L et al (2020) Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5(12):e661–e671CrossRefPubMed Jia L et al (2020) Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5(12):e661–e671CrossRefPubMed
7.
Zurück zum Zitat Sachdev PS et al (2015) The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC collaboration. Plos One 10(11):e142388CrossRefPubMedPubMedCentral Sachdev PS et al (2015) The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC collaboration. Plos One 10(11):e142388CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Trittschuh EH et al (2011) Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. J Alzheimers Dis 25(1):163–173CrossRefPubMedPubMedCentral Trittschuh EH et al (2011) Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. J Alzheimers Dis 25(1):163–173CrossRefPubMedPubMedCentral
9.
10.
Zurück zum Zitat Doruk H et al (2010) The relationship between body mass index and incidental mild cognitive impairment, Alzheimer’s disease, and Vascular Dementia in elderly. J Nutr Health Aging 14(10):834–838CrossRefPubMed Doruk H et al (2010) The relationship between body mass index and incidental mild cognitive impairment, Alzheimer’s disease, and Vascular Dementia in elderly. J Nutr Health Aging 14(10):834–838CrossRefPubMed
11.
Zurück zum Zitat Kiral K et al (2013) Detection of memory impairment in a community-based system: a collaborative study. Health Soc Work 38(2):89–96CrossRefPubMed Kiral K et al (2013) Detection of memory impairment in a community-based system: a collaborative study. Health Soc Work 38(2):89–96CrossRefPubMed
12.
Zurück zum Zitat McLeod S (2019) Z‑score: definition, calculation and interpretation. Simply Psychol 1:1–7 McLeod S (2019) Z‑score: definition, calculation and interpretation. Simply Psychol 1:1–7
13.
Zurück zum Zitat Brodaty H et al (2013) Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement 9(3):310–317e1CrossRefPubMed Brodaty H et al (2013) Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement 9(3):310–317e1CrossRefPubMed
14.
Zurück zum Zitat Robertson K et al (2019) Using varying diagnostic criteria to examine mild cognitive impairment prevalence and predict dementia incidence in a community-based sample. J Alzheimers Dis 68(4):1439–1451CrossRefPubMed Robertson K et al (2019) Using varying diagnostic criteria to examine mild cognitive impairment prevalence and predict dementia incidence in a community-based sample. J Alzheimers Dis 68(4):1439–1451CrossRefPubMed
15.
Zurück zum Zitat Caffo AO et al (2022) The prevalence of amnestic and non-amnestic mild cognitive impairment and its association with different lifestyle factors in a south Italian elderly population. Int J Environ Res Public Health 19(5):3097CrossRefPubMedPubMedCentral Caffo AO et al (2022) The prevalence of amnestic and non-amnestic mild cognitive impairment and its association with different lifestyle factors in a south Italian elderly population. Int J Environ Res Public Health 19(5):3097CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Luck T et al (2010) Incidence of mild cognitive impairment: a systematic review. Dement Geriatr Cogn Disord 29(2):164–175CrossRefPubMed Luck T et al (2010) Incidence of mild cognitive impairment: a systematic review. Dement Geriatr Cogn Disord 29(2):164–175CrossRefPubMed
17.
18.
Zurück zum Zitat Unverzagt FW et al (2001) Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 57(9):1655–1662CrossRefPubMed Unverzagt FW et al (2001) Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 57(9):1655–1662CrossRefPubMed
19.
Zurück zum Zitat Busse A et al (2003) Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 182:449–454CrossRefPubMed Busse A et al (2003) Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 182:449–454CrossRefPubMed
20.
Zurück zum Zitat Alexander M et al (2015) Age-stratified prevalence of mild cognitive impairment and dementia in European populations: a systematic review. J Alzheimers Dis 48(2):355–359CrossRefPubMed Alexander M et al (2015) Age-stratified prevalence of mild cognitive impairment and dementia in European populations: a systematic review. J Alzheimers Dis 48(2):355–359CrossRefPubMed
21.
Zurück zum Zitat Tervo S et al (2004) Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 17(3):196–203CrossRefPubMed Tervo S et al (2004) Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 17(3):196–203CrossRefPubMed
22.
Zurück zum Zitat Solfrizzi V et al (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63(10):1882–1891CrossRefPubMed Solfrizzi V et al (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63(10):1882–1891CrossRefPubMed
23.
Zurück zum Zitat Degen C et al (2022) Differences in cognitive functioning in two birth cohorts born 20 years apart: data from the interdisciplinary longitudinal study of ageing. Brain Sci 12(2):271CrossRefPubMedPubMedCentral Degen C et al (2022) Differences in cognitive functioning in two birth cohorts born 20 years apart: data from the interdisciplinary longitudinal study of ageing. Brain Sci 12(2):271CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kivipelto M et al (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14(11):653–666CrossRefPubMed Kivipelto M et al (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14(11):653–666CrossRefPubMed
25.
Zurück zum Zitat Casaletto KB et al (2020) Late-life physical and cognitive activities independently contribute to brain and cognitive resilience. J Alzheimers Dis 74(1):363–376CrossRefPubMedPubMedCentral Casaletto KB et al (2020) Late-life physical and cognitive activities independently contribute to brain and cognitive resilience. J Alzheimers Dis 74(1):363–376CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Horder H et al (2018) Midlife cardiovascular fitness and dementia: A 44-year longitudinal population study in women. Neurology 90(15):e1298–e1305CrossRefPubMedPubMedCentral Horder H et al (2018) Midlife cardiovascular fitness and dementia: A 44-year longitudinal population study in women. Neurology 90(15):e1298–e1305CrossRefPubMedPubMedCentral
27.
28.
Zurück zum Zitat Chapman SB et al (2015) Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors. Cereb Cortex 25(2):396–405MathSciNetCrossRefPubMed Chapman SB et al (2015) Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors. Cereb Cortex 25(2):396–405MathSciNetCrossRefPubMed
Metadaten
Titel
Prevalence and risk factors of mild cognitive impairment in a tertiary care setting in Turkey
verfasst von
Betül Gülsüm Yavuz Veizi, MD
Candeniz Avci, MD
Hatice Tuğba Yazir, MD
Mehmet Ilkin Naharci, MD, PhD
Publikationsdatum
28.04.2023
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 2/2024
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-023-02181-4

Weitere Artikel der Ausgabe 2/2024

Zeitschrift für Gerontologie und Geriatrie 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.